Mentioned in ?
References in periodicals archive ?
List of 14-3-3 eta ACR 2014 conference proceedings to be presented at the Boston Convention & Exhibition Center
Investigators will present the studies listed in the schedule below, which to date along with other publications, represent over 2000 patients evaluated with the 14-3-3 eta blood test.
This follows the very recent publication of a study describing the novel mechanism by which 14-3-3 eta promotes disease.
Marotta will be giving a web-based presentation on Friday, May 30th at 9:00 am PST entitled "How does the soluble mechanistic biomarker 14-3-3 eta assist in the management of Rheumatoid Arthritis?
Walter Maksymowych, the principal investigator of several 14-3-3 eta studies as well as the International Chair of the Outcomes Measures in Rheumatology Clinical Trials Soluble Biomarker Subcommittee and Medical Research Professor of Medicine and Rheumatologist at the University of Alberta, says "The body of evidence is now growing at such a rapid rate that we are seeing applications emerge in autoimmune diseases such as Ankylosing Spondylitis, where there are no useful diagnostic blood tests available.